Figure 3 from PPARδ Orchestrates a Prometastatic Metabolic Response to Microenvironmental Cues in Pancreatic Cancer
<p><i>PPARD</i> expression is linked to metabolic switch and EMT in patients with PDAC. <b>A,</b> Expression levels of <i>PPARD</i> in PDAC tumors (T) vs. surrounding normal tissue (N) included in the TCGA and GTEx projects. <b>B,</b> Patients were dichotomized for <i>PPARD</i> expression [higher (<i>n</i> = 58) and lower (<i>n</i> = 81) expression compared with the mean; RNA-seq V2 RSEM values]. Kaplan–Meier curves for disease-free survival are shown. Dotted lines denote the confidence intervals. Survival, 19.48 vs. 13.53 months. <b>C</b> and <b>D,</b> A TMA with 108 cases was stained by IHQ using an anti–PPARδ antibody. Representative images depicting different signal intensities (weak vs. strong) and localizations (nuclear vs. cytoplasmatic) are shown in <b>C</b>. Magnification, ×400. Scale bar, 50 μm. Arrows, stained cancer cells. <b>D,</b> Signal intensity was scored by Allred immunoreactive score, and patients were dichotomized into low (<i>n</i> = 34; scores 0–6) vs. high (<i>n</i> = 59; scores 7–8) PPARδ expression groups. Kaplan–Meier curves for overall survival are shown. Dotted lines denote the confidence intervals. Survival, 17.5 vs. 11 months. <b>E,</b> Correlation between <i>PPARD</i> tumor expression levels family members and an EMT-associated signature composed of <i>SNAI1</i>, <i>SNAI2</i>, and <i>ZEB1</i>. <b>F,</b> Gene sets enriched in the transcriptional profile of tumors belonging to the top <i>PPARD</i> high-expression group compared with the bottom low-expression group in the TCGA data series (PAAD, pancreatic adenocarcinoma). Shown are the normalized enrichment score (NES) values for each pathway using the Hallmark gene sets, meeting the significance criteria: nominal <i>P</i> value of < 0.05, FDR < 25%. <b>G,</b> Enrichment plot for TNFα, EMT, glycolysis, and hypoxia hallmarks in <i>PPARD</i>-high vs. -low samples shown in <b>F</b>, indicating values of normalized enrichment score and FDR <i>q</i> values. <b>H,</b> Representative images of costaining of PPARδ (nuclear and cytoplasmatic, red) and HIF1α (nuclear brown) by IHQ in several patients shown in <b>C</b> and <b>D</b>. Magnification, ×400. Scale bar, 50 μm. Arrows, costained cancer cells. See also Supplementary Fig. S6.</p>
Authors
- Mariia Yuneva (ORCID: https://orcid.org/0000-0003-3455-9374)
- Petra Jagušt (ORCID: https://orcid.org/0000-0001-5291-251X)
- Jelena Zurkovic (ORCID: https://orcid.org/0000-0002-5932-4849)
- David Barneda (ORCID: https://orcid.org/0000-0002-4436-4100)
- Bruno Sáinz (ORCID: https://orcid.org/0000-0003-4829-7651)
- Patricia Sancho (ORCID: https://orcid.org/0000-0002-1092-5395)
- Beatriz Parejo-Alonso (ORCID: https://orcid.org/0000-0002-5393-4283)
- Laura Ruíz-Cañas (ORCID: https://orcid.org/0000-0002-4373-2573)
- Matthias M. Gaida (ORCID: https://orcid.org/0000-0003-1499-7772)
- Sara Maria David Trabulo (ORCID: https://orcid.org/0000-0002-3178-2119)
- Shanthini Mary Crusz (ORCID: https://orcid.org/0000-0003-0687-0149)
- Pilar Espiau-Romera (ORCID: https://orcid.org/0000-0002-7165-199X)
- Christopher Heeschen (ORCID: https://orcid.org/0000-0002-1158-8554)
- Sara Compte-Sancerni (ORCID: https://orcid.org/0000-0003-2297-7368)
- Sarah Courtois (ORCID: https://orcid.org/0000-0001-8572-2499)
- Pilar Irún (ORCID: https://orcid.org/0000-0003-3392-7200)
- Ulf Schmitz (ORCID: https://orcid.org/0000-0001-5806-4662)
- Laure Penin-Peyta
- Ming-Hsin Yang (ORCID: https://orcid.org/0000-0001-9093-1009)
- Ángel Lanas (ORCID: https://orcid.org/0000-0001-5932-2889)
- Meng‐Lay Lin (ORCID: https://orcid.org/0000-0002-1187-1050)
- Alba Royo-García (ORCID: https://orcid.org/0000-0002-5079-6890)
- Jiajia Tang (ORCID: https://orcid.org/0000-0002-7775-827X)
- Quan Zheng (ORCID: https://orcid.org/0000-0002-4512-9233)
- Christoph Thiele (ORCID: https://orcid.org/0000-0001-5161-2558)
- Shenghui Huang (ORCID: https://orcid.org/0000-0002-3714-1961)
- Andrés Gordo-Ortiz
Publication Details
- Published
- 2025-09-02
- DOI
- https://doi.org/10.1158/0008-5472.30029495
- Primary Topic
- Peroxisome Proliferator-Activated Receptors
- Type
- article
- Field-Weighted Citation Impact
- 0.00